ASML

1,177.4

+5.16%↑

SAP

147.74

+0.75%↑

IFX

39.74

+3.84%↑

NOKIA.FI

6.99

+1.45%↑

STMPA.FR

29.7

+4.65%↑

ASML

1,177.4

+5.16%↑

SAP

147.74

+0.75%↑

IFX

39.74

+3.84%↑

NOKIA.FI

6.99

+1.45%↑

STMPA.FR

29.7

+4.65%↑

ASML

1,177.4

+5.16%↑

SAP

147.74

+0.75%↑

IFX

39.74

+3.84%↑

NOKIA.FI

6.99

+1.45%↑

STMPA.FR

29.7

+4.65%↑

ASML

1,177.4

+5.16%↑

SAP

147.74

+0.75%↑

IFX

39.74

+3.84%↑

NOKIA.FI

6.99

+1.45%↑

STMPA.FR

29.7

+4.65%↑

ASML

1,177.4

+5.16%↑

SAP

147.74

+0.75%↑

IFX

39.74

+3.84%↑

NOKIA.FI

6.99

+1.45%↑

STMPA.FR

29.7

+4.65%↑

Strona główna・Stock List・Claranova

A
Claranova

Open

Buy Sell

Overview

Share price change

24h

Current

Min

Max

Key metrics
By Trading Economics
Income	-37M
Sales	-176M
Profit margin	21.274
Employees	717
EBITDA	-17M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+276.81% upside

Market Stats
By TradingEconomics
Market Cap	61M
Previous open	0
Previous close	0

Technical Score

By Trading Central

Confidence

Bullish Evidence

2.515 / 2.61 Support & Resistance

Claranova Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

31 mar 2026, 23:31 UTC

Hot Stocks

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Earnings

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 kwi 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Acquisitions, Mergers, Takeovers

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Market Talk

Major News Events

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Earnings

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Market Talk

Earnings

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Earnings

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Earnings

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Acquisitions, Mergers, Takeovers

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Earnings

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Earnings

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Earnings

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Earnings

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Earnings

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Earnings

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Earnings

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Earnings

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Market Talk

Earnings

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Earnings

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Earnings

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Earnings

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Earnings

Nike CEO: Converse Remains Important to Portfolio

Peer Comparison

Price change

Claranova Forecast

Price Target

By TipRanks

276.81% upside

12 Months Forecast

Average 2.6 EUR 276.81%

High 2.6 EUR

Low 2.6 EUR

Based on 1 Wall Street analysts offering 12 month price targets forClaranova - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to Claranova - Dist in the past 3 months.

Technical Score

By Trading Central

2.515 / 2.61Support & Resistance

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bullish.

Financials

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Claranova

Claranova SE, a technology company, engages in personalized e-commerce, software publishing, and internet of things (IoT) management in France, the United States, the United Kingdom, Germany, other European countries, and internationally. It operates in three segments: PlanetArt, Avanquest, and myDevices. The PlanetArt segment offers photos, frames, personalized books, and FreePrints mobile applications. The Avanquest segment provides antivirus, ad blocker, cleaning, and optimization tools under the Adaware brand; document management tools under the SodaPDF brand; and photo editor software and applications developed under the inPixio brand. The myDevices segment offers IoT solutions. Claranova SE was incorporated in 1984 and is headquartered in Courbevoie, France.